Inactive Instrument

BLIRT S.A.

Equities

BLR

PLBLIRT00018

BLIRT S.A. Reports Earnings Results for the Full Year Ended December 31, 2021

February 14, 2022 at 12:24 pm IST

BLIRT S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was PLN 45.33 million compared to PLN 67.61 million a year ago. Net income was PLN 8.73 million compared to PLN 22.25 million a year ago.

Latest news about BLIRT S.A.

BLIRT S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Qiagen N.V. completed the acquisition of 96.3% stake in BLIRT S.A. from N50 Cyprus Limited, Marian Popinigis and others for $64 million.	30/22/30	CI
Sector Update: Health Care Stocks Edging Lower Ahead of Wednesday Close	12/22/12	MT
Sector Update: Health Care Stocks Still Hanging on for Small Advance	11/22/11	MT
Qiagen to Acquire 96% Stake In BLIRT for Undisclosed Sum	11/22/11	MT
Qiagen N.V. agreed to acquire 96.3% stake in BLIRT S.A. from N50 Cyprus Limited, Marian Popinigis and others.	11/22/11	CI
BLIRT S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	14/22/14	CI
BLIRT S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	14/22/14	CI
BLIRT S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
BLIRT S.A. Announces Earnings Results for the Second Quarter Ended June 30, 2021	12/21/12	CI
Blirt S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/21/13	CI
BLIRT S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	15/21/15	CI
Agencja Rozwoju Pomorza S.A. cancelled the acquisition of the remaining 76.91% stake in Transmedium Tadeusz Macha from BLIRT S.A..	03/19/03	CI
Agencja Rozwoju Pomorza S.A. signed a share purchase agreement to acquire the remaining 76.91% stake in Transmedium Tadeusz Macha from BLIRT S.A. for approximately PLN 160 million.	03/18/03	CI
BLIRT S.A. announced that it has received PLN 0.84 million in funding from N50 Cyprus Limited	09/18/09	CI
BLIRT S.A. announced that it expects to receive PLN 0.84 million in funding from N50 Cyprus Limited	22/18/22	CI

Chart BLIRT S.A.

Duration

Period

More charts

Company Profile

Blirt SA is a Poland-based company, which is involved in the production of specialized enzymes and reagents dedicated to use in Life Science. The Company develops protein production methods (upstream and downstream) and conducting production on an industrial scale. Other product groups in which entity is specializing are kits for nucleic acid isolation, reverse transcription reagents and Real-Time PCR.

Sector

More about the company